GPT and tuberculosis: While this potential protective effect is biologically plausible and consistent with the intervention’s design contrasts with traditional TDM studies reporting 5–7% hepatotoxicity (Thu et al., 2024), likely due to our dynamic dose adjustments based on real-time ALT/AST trends—an approach recently endorsed by the 2024 WHO TB Guidelines (WHO, 2024).